# A Study in Healthy Men to Test How Well Different Doses of BI 3802876 Are Tolerated

> **NCT06081530** · PHASE1 · COMPLETED · sponsor: **Boehringer Ingelheim** · enrollment: 59 (actual)

## Conditions studied

- Healthy

## Interventions

- **DRUG:** BI 3802876
- **DRUG:** Placebo matching BI 3802876

## Key facts

- **NCT ID:** NCT06081530
- **Lead sponsor:** Boehringer Ingelheim
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2023-10-27
- **Primary completion:** 2025-03-20
- **Final completion:** 2025-03-20
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2025-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06081530

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06081530, "A Study in Healthy Men to Test How Well Different Doses of BI 3802876 Are Tolerated". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06081530. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*